Why Did Netflix Buy Warner Bros?
Following a bidding war, Netflix (NASDAQ:NFLX) has announced its intention…
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2023-09-30 | 2024-09-30 | 2025-09-30 | 2024-09-30 | 2025-09-30 | |
| Income Statement | ||||||
| Revenue | $4.2B | $4.8B | $5.5B | $1.3B | $1.4B | |
| Gross Profit | $906.2M | $932.7M | $1B | $242.1M | $256.6M | |
| Operating Income | $303.3M | $319.4M | $333.4M | $85.1M | $84.5M | |
| EBITDA | $380.1M | $381.2M | $401.3M | $100.3M | $101.6M | |
| Diluted EPS | $1.42 | $1.19 | $1.26 | $0.31 | $0.32 | |
| Period Ending | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | 2025-09-30 | |
|---|---|---|---|---|---|---|
| Balance Sheet | ||||||
| Current Assets | $811.2M | $952M | $1.1B | $1.3B | $1.3B | |
| Total Assets | $2.8B | $3.1B | $3.2B | $3.4B | $3.5B | |
| Current Liabilities | $485.7M | $586.8M | $624.1M | $763.2M | $823.9M | |
| Total Liabilities | $1.7B | $1.7B | $1.8B | $2B | $2.1B | |
| Total Equity | $1.1B | $1.3B | $1.4B | $1.4B | $1.4B | |
| Total Debt | $1.2B | $1.1B | $1.1B | $1.2B | $1.3B | |
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2023-09-30 | 2024-09-30 | 2025-09-30 | 2024-09-30 | 2025-09-30 | |
| Cash Flow Statement | ||||||
| Cash Flow Operations | $363.8M | $338.2M | $258.7M | $160.4M | $139.4M | |
| Cash From Investing | -$44.4M | -$41M | -$158.6M | -$9.7M | -$11.7M | |
| Cash From Financing | -$188.4M | -$200.7M | -$273.2M | -$44.6M | -$16.7M | |
| Free Cash Flow | $323.6M | $293.1M | $220.7M | $150.7M | $130.2M | |
Option Care Health, Inc. engages in the provision of home and alternate site infusion services. The firm provides infusion therapy and other ancillary healthcare services through a national network of full-service pharmacies. The company contracts with managed care organizations, third-party payers, hospitals, physicians, and other referral sources to provide pharmaceuticals and complex compounded solutions to patients for intravenous delivery in the patients’ homes or other nonhospital settings. Its home infusion services consist of anti-infectives, nutrition support, bleeding disorder therapies, immunoglobulin therapy, and other therapies for chronic and acute conditions. The company was founded in 1996 and is headquartered in Bannockburn, IL.
In the current month, OPCH has received 6 Buy ratings 1 Hold ratings, and 0 Sell ratings. The OPCH average analyst price target in the past 3 months is $35.30.
According to analysts, the consensus estimate is that Option Care Health, Inc. share price will rise to $35.30 per share over the next 12 months.
Analysts are divided on their view about Option Care Health, Inc. share price and where it will be in the next 12 months. The majority of analysts rate the stock a Buy. However, a smaller subset of analysts suggest that Option Care Health, Inc. is a Sell and believe this share price will drop from its current level to $30.00.
The price target for Option Care Health, Inc. over the next 1-year time period is forecast to be $35.30 according to 7 Wall Street analysts, 6 of them rate the stock a Buy, 0 rate the stock a Sell, and 1 analyst rates the stock a Hold.
According to Wall Street analysts, the consensus rating for Option Care Health, Inc. is a Buy. 6 of 7 analysts rate the stock a Buy at this time.
You can purchase shares of Option Care Health, Inc. via an online brokerage firm such as TD Ameritrade.com, thinkorswim.com, e-trade.com, or Schwab.com. Many other digital online brokerages exist such as RobinHood and Webull where you can purchase Option Care Health, Inc. shares.
Option Care Health, Inc. was last trading at $30.63 per share. This represents the most recent stock quote for Option Care Health, Inc.. Yesterday, Option Care Health, Inc. closed at $29.89 per share.
In order to purchase Option Care Health, Inc. stock online, open a brokerage account, deposit funds into the account, and select an order type to purchase shares whether it be market or limit.
Signup to receive the latest stock alerts
Following a bidding war, Netflix (NASDAQ:NFLX) has announced its intention…
Fintech platform SoFi (NASDAQ:SOFI) has stumbled in recent days, selling…
Recently, online brokerage Robinhood (NASDAQ:HOOD) has been focused on introducing…
Market Cap: $4.4T
P/E Ratio: 62x
Market Cap: $4.1T
P/E Ratio: 37x
Market Cap: $3.9T
P/E Ratio: 40x
SMX (Security Matters) Plc [SMX] is down 59.64% over the past day.
Kymera Therapeutics, Inc. [KYMR] is up 41.67% over the past day.
Praxis Precision Medicines, Inc. [PRAX] is up 9.18% over the past day.